Noni as an anxiolytic and sedative: A mechanism involving its gamma-aminobutyric acidergic effects

Phytomedicine

Volumn 14, Issue 7-8, 2007, Pages 517-522

  Deng, S ^a   West, B J ^a   Palu, A K ^a   Zhou, B N ^a   Jensen, C J ^a  

^a Research and Development Department   (United States)

Author keywords

Anxiolytic; GABAa; Morinda citrifolia; Noni; Sedative

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANXIOLYTIC AGENT; BUTANOL; METHANOL; MORINDA CITRIFOLIA EXTRACT; MUSCIMOL; SEDATIVE AGENT; WATER;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; MORINDA CITRIFOLIA; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; CELL MEMBRANE; FRUIT; GABA AGONISTS; HYPNOTICS AND SEDATIVES; INHIBITORY CONCENTRATION 50; MEDICINE, TRADITIONAL; MORINDA; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

MORINDA CITRIFOLIA;

EID: 34447565946     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.04.005     Document Type: Article

References (30)

1. Angst J., Sellaro R., Merikangas K.R., and Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiat. Scand. 104 (2001) 110-116
2. Baureithel K.H., Buter K.B., Engesser A., Burkard W., and Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm. Acta Helv. 72 (1997) 153-157
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
4. 3H] Flunitrazepam: its advantages as a ligand for the identification of benzodiazepine receptors in rat brain membranes. Res. Commun. Chem. Pathol. Pharmacol. 22 (1978) 597-600
5. Dannon P.N., Lowengrub K., Iancu I., and Kotler M. Paroxetine in panic disorder: clinical management and long-term follow-up. Expert Rev. Neurother. 4 (2004) 191-198
6. Evers M.M., and Marin D.B. Mood disorders. Effective management of major depressive disorder in the geriatric patient. Geriatrics 57 (2002) 36-40 quiz 41
7. Gorman J.M. New molecular targets for antianxiety interventions. J. Clin. Psychiat. 64 Suppl. 3 (2003) 28-35
8. Gottesmann C. GABA mechanisms and sleep. Neuroscience 111 (2002) 231-239
9. Hirazumi A., and Furusawa E. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) with antitumor activity. Phytother. Res. 13 (1999) 380-387
10. Jorm A.F. Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span. Psychol. Med. 30 (2000) 11-22
11. Kalandakanond S., Pandaranandaga J., Komolvanich S., and Poonyachoti S. A study on the anxiolytic effect of juice from the fruit of Noni (Morinda citrifolia L. Rubiaceae) on wistar rats. Thai. J. Vet. Med. 34 (2004) 132
12. Kamiya K., Tanaka Y., Endang H., Umar M., and Satake T. Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation. J. Agric. Food Chem. 52 (2004) 5843-5848
13. Kent J.M., Mathew S.J., and Gorman J.M. Molecular targets in the treatment of anxiety. Biol. Psychiat. 52 (2002) 1008-1030
14. Langford J., Doughty A., Wang M., Clayton L., and Babich M. Effects of Morinda citrifolia on quality of life and auditory function in postmenopausal women. J. Altern. Complement. Med. 10 (2004) 737-739
15. Lebert F. Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias. Press. Med. 32 (2003) 1181-1186
16. McClatchey W. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integrated. Cancer Ther. 1 (2002) 110-120
17. Miller A.L. St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions. Altern. Med. Rev. 3 (1998) 18-26
18. Mohler H. GABAergic synaptic transmission. Regulation by drugs. Arzneimittelforschung 42 (1992) 211-214
19. Mohler H., Crestani F., and Rudolph U. GABAA-receptor subtypes: a new pharmacology. Curr. Opin. Pharmacol. 1 (2001) 22-25
20. Pawlus A.D., Su B.-N., Keller W.J., and Kinghorn A.D. An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (Noni). J. Nat. Prod. 68 (2005) 1720-1722
21. Rolland A., Fleurentin J., Lanhers M.C., Younos C., Misslin R., Mortier F., and Pelt J.M. Behavioural effects of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties. Planta Med. 57 (1991) 212-216
22. Rudolph U. Identification of molecular substrate for the attenuation of anxiety: a step toward the development of better anti-anxiety drugs. Sci. World J. 1 (2001) 192-193
23. Sartorius N., Ustun T.B., Lecrubier Y., and Wittchen H.U. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br. J. Psychiat. Suppl. 30 (1996) 38-43
24. 3H]flunitrazepam binding. Life Sci. 24 (1979) 351-357
25. Su B.-N., Pawlus A.D., Jung H.-A., Keller W.J., McLaughlin J.L., and Kinghorn A.D. Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J. Nat. Prod. 68 (2005) 592-595
26. Wang M.-Y., West B.J., Jensen C.J., Nowicki D., Su C., Palu A.K., and Anderson G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol. Sin. 23 (2002) 1127-1141
27. West B.J., Jensen C.J., and Westendorf J. Noni juice is not hepatotoxic. World J. Gastroenterol. 12 (2006) 3616-3619
28. West B.J., Jensen C.J., Westendorf J., and White L.D. A safety review of Noni fruit juice. J. Food Sci. 71 (2006) R100-R106
29. Younos C., Rolland A., Fleurentin J., Lanhers M.C., Misslin R., and Mortier F. Analgesic and behavioural effects of Morinda citrifolia. Planta Med. 56 (1990) 430-434
30. Yuan C.S., Mehendale S., Xiao Y., Aung H.H., Xie J.T., and Ang-Lee M.K. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth. Analg. 98 (2004) 353-358